{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:27:08Z","timestamp":1726273628775},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,13]]},"DOI":"10.7759\/cureus.69340","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T14:22:07Z","timestamp":1726237327000},"source":"Crossref","is-referenced-by-count":0,"title":["The Efficacy and Safety of Antifungal Agents for Managing Oral Candidiasis in Oncologic Patients: A Systematic Review With Network Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Amanda F","family":"de Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor L","family":"Fagundes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia B","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena L","family":"Borba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda S","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6010015","article-title":"Oral candidiasis: a disease of opportunity","volume":"6","author":"Vila T","year":"2020","unstructured":"Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a disease of opportunity. J Fungi (Basel). 2020, 6:10.3390\/jof6010015","journal-title":"J Fungi (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58050576","article-title":"Prevalence and antifungal susceptibility profile of oral Candida spp. isolates from a hospital in Slovakia","volume":"58","author":"\u010cern\u00e1kov\u00e1 L","year":"2022","unstructured":"\u010cern\u00e1kov\u00e1 L, L\u00ed\u0161kov\u00e1 A, Lengyelov\u00e1 L, Rodrigues CF. Prevalence and antifungal susceptibility profile of oral Candida spp. isolates from a hospital in Slovakia. Medicina (Kaunas). 2022, 58:576. 10.3390\/medicina58050576","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/581795","article-title":"Oral complications and management strategies for patients undergoing cancer therapy","volume":"2014","author":"Wong HM","year":"2014","unstructured":"Wong HM. Oral complications and management strategies for patients undergoing cancer therapy. Sci World J. 2014, 2014:581795. 10.1155\/2014\/581795","journal-title":"Sci World J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13324","article-title":"Effectiveness of fluconazole as antifungal prophylaxis in cancer patients undergoing chemotherapy, radiotherapy, or immunotherapy: systematic review and meta-analysis","volume":"131","author":"Ram\u00edrez-Carmona W","year":"2023","unstructured":"Ram\u00edrez-Carmona W, Fernandes GL, D\u00edaz-Fabregat B, Oliveira EC, do Prado RL, Pessan JP, Monteiro DR. Effectiveness of fluconazole as antifungal prophylaxis in cancer patients undergoing chemotherapy, radiotherapy, or immunotherapy: systematic review and meta-analysis. APMIS. 2023, 131:668-84. 10.1111\/apm.13324","journal-title":"APMIS"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2020.104906","article-title":"Prevalence and susceptibility profile of Candida spp. isolated from patients in cancer therapy","volume":"119","author":"Souza E Silva VC","year":"2020","unstructured":"Souza E Silva VC, Oliveira VC, Sousa \u00c1FL, Bim FL, Macedo AP, Andrade D, Watanabe E. Prevalence and susceptibility profile of Candida spp. isolated from patients in cancer therapy. Arch Oral Biol. 2020, 119:104906. 10.1016\/j.archoralbio.2020.104906","journal-title":"Arch Oral Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0757.2008.00291.x","article-title":"Oral mucosal fungal infections","volume":"49","author":"Samaranayake LP","year":"2009","unstructured":"Samaranayake LP, Keung Leung W, Jin L. Oral mucosal fungal infections. Periodontol 2000. 2009, 49:39-59. 10.1111\/j.1600-0757.2008.00291.x","journal-title":"Periodontol 2000"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2017.01.943","article-title":"Network meta-analysis: a technique to gather evidence from direct and indirect comparisons","volume":"15","author":"Tonin FS","year":"2017","unstructured":"Tonin FS, Rotta I, Mendes AM, Pontarolo R. Network meta-analysis: a technique to gather evidence from direct and indirect comparisons. Pharm Pract (Granada). 2017, 15:943. 10.18549\/PharmPract.2017.01.943","journal-title":"Pharm Pract (Granada)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2021.10.023","article-title":"Comparison of topical antifungal agents for oral candidiasis treatment: a systematic review and meta-analysis","volume":"133","author":"Xiao Y","year":"2022","unstructured":"Xiao Y, Yuan P, Sun Y, et al.. Comparison of topical antifungal agents for oral candidiasis treatment: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022, 133:282-91. 10.1016\/j.oooo.2021.10.023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/life12111677","article-title":"Nystatin effectiveness in oral candidiasis treatment: a systematic review & meta-analysis of clinical trials","volume":"12","author":"Rai A","year":"2022","unstructured":"Rai A, Misra SR, Panda S, Sokolowski G, Mishra L, Das R, Lapinska B. Nystatin effectiveness in oral candidiasis treatment: a systematic review &amp; meta-analysis of clinical trials. Life (Basel). 2022, 12:10.3390\/life12111677","journal-title":"Life (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106614","article-title":"Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses","volume":"60","author":"Domingos EL","year":"2022","unstructured":"Domingos EL, Vilhena RO, Santos JM, et al.. Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses. Int J Antimicrob Agents. 2022, 60:106614. 10.1016\/j.ijantimicag.2022.106614","journal-title":"Int J Antimicrob Agents"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15782","article-title":"Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice","volume":"33","author":"Taudorf EH","year":"2019","unstructured":"Taudorf EH, Jemec GB, Hay RJ, Saunte DM. Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. J Eur Acad Dermatol Venereol. 2019, 33:1863-73. 10.1111\/jdv.15782","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003940.pub3","article-title":"Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children","volume":"2010","author":"Pienaar ED","year":"2010","unstructured":"Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev. 2010, 2010:CD003940. 10.1002\/14651858.CD003940.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prosdent.2019.12.025","article-title":"Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis","volume":"125","author":"Fang J","year":"2021","unstructured":"Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis. J Prosthet Dent. 2021, 125:257-65. 10.1016\/j.prosdent.2019.12.025","journal-title":"J Prosthet Dent"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13588","article-title":"Antifungal agents in preventing oral candidiasis in clinical oncology: a network meta-analysis","volume":"27","author":"Shen Loo Y","year":"2021","unstructured":"Shen Loo Y, Yee Wong T, Veettil SK, Se Wong P, Gopinath D, Mooi Ching S, Kunnath Menon R. Antifungal agents in preventing oral candidiasis in clinical oncology: a network meta-analysis. Oral Dis. 2021, 27:1631-43. 10.1111\/odi.13588","journal-title":"Oral Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","volume":"14","author":"Hoaglin DC","year":"2011","unstructured":"Hoaglin DC, Hawkins N, Jansen JP, et al.. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health. 2011, 14:429-37. 10.1016\/j.jval.2011.01.011","journal-title":"Value Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R Package for Network Meta-Analysis Using Frequentist Methods","volume":"106","author":"Balduzzi S","year":"2023","unstructured":"Balduzzi S, R\u00fccker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, Schwarzer G. netmeta: an R Package for Network Meta-Analysis Using Frequentist Methods. J Stat Soft. 2023, 106:1-40. 10.18637\/jss.v106.i02","journal-title":"J Stat Soft"},{"key":"ref19","article-title":"NMAstudio: a fully interactive web-application for producing and visualising network meta-analyses","author":"Tianqi Y","year":"2023","unstructured":"Tianqi Y, Silva M, Chaimani A. NMAstudio: a fully interactive web-application for producing and visualising network meta-analyses. Cochrane Colloquium. 2023,","journal-title":"Cochrane Colloquium"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou A","year":"2020","unstructured":"Nikolakopoulou A, Higgins JP, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, Salanti G. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020, 17:e1003082. 10.1371\/journal.pmed.1003082","journal-title":"PLoS Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23152","article-title":"Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer","volume":"112","author":"Bensadoun RJ","year":"2008","unstructured":"Bensadoun RJ, Daoud J, El Gueddari B, et al.. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer. 2008, 112:204-11. 10.1002\/cncr.23152","journal-title":"Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197408)34:2<246::aid-cncr2820340203>3.0.co;2-j","article-title":"Oral monilia study on patients with head and neck cancer during radiotherapy","volume":"34","author":"Chen TY","year":"1974","unstructured":"Chen TY, Webster JH. Oral monilia study on patients with head and neck cancer during radiotherapy. Cancer. 1974, 34:246-9. 10.1002\/1097-0142(197408)34:2&lt;246::aid-cncr2820340203&gt;3.0.co;2-j","journal-title":"Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0266-4356(96)90130-8","article-title":"A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours","volume":"1","author":"Finlay PM","year":"1996","unstructured":"Finlay PM, Richardson MD, Robertson AG. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours. Br J Oral Maxillofac Surg. 1996, 1:23-5. 10.1016\/s0266-4356(96)90130-8","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.6.1060","article-title":"Ketoconazole and candidiasis: a controlled study","volume":"147","author":"Hughes WT","year":"1983","unstructured":"Hughes WT, Bartley DL, Patterson GG, Tufenkeji H. Ketoconazole and candidiasis: a controlled study. J Infect Dis. 1983, 147:1060-3. 10.1093\/infdis\/147.6.1060","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000239459","article-title":"Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients","volume":"42","author":"Lake DE","year":"1996","unstructured":"Lake DE, Kunzweiler J, Beer M, Buell DN, Islam MZ. Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients. Chemotherapy. 1996, 42:308-14. 10.1159\/000239459","journal-title":"Chemotherapy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.supplement_3.s364","article-title":"Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole","volume":"12 Suppl 3","author":"Meunier F","year":"1990","unstructured":"Meunier F, Aoun M, Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Rev Infect Dis. 1990, 12 Suppl 3:S364-8. 10.1093\/clinids\/12.supplement_3.s364","journal-title":"Rev Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.03.003","article-title":"An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis","volume":"40","author":"Oude Lashof AM","year":"2004","unstructured":"Oude Lashof AM, De Bock R, Herbrecht R, et al.. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. Eur J Cancer. 2004, 40:1314-9. 10.1016\/j.ejca.2004.03.003","journal-title":"Eur J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1979.03630430036012","article-title":"Oropharyngeal candidiasis treated with a troche form of clotrimazole","volume":"139","author":"Yap BS","year":"1979","unstructured":"Yap BS, Bodey GP. Oropharyngeal candidiasis treated with a troche form of clotrimazole. Arch Intern Med. 1979, 139:656-7. 10.1001\/archinte.1979.03630430036012","journal-title":"Arch Intern Med"},{"key":"ref29","article-title":"Comparison of clotrimazole troche and nystatin vaginal tablet in the treatment of oropharyngeal candidiasis","volume":"27","author":"Lawson RD","year":"1980","unstructured":"Lawson RD, Bodey GP. Comparison of clotrimazole troche and nystatin vaginal tablet in the treatment of oropharyngeal candidiasis. Curr Therapeut Res. 1980, 27:774-9.","journal-title":"Curr Therapeut Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/BF03258243","article-title":"Oral treatment of oropharyngeal candidiasis with nystatin versus ketoconazole in cancer patients","volume":"2","author":"Meunier F","year":"1990","unstructured":"Meunier F, G\u00e9rain J, Snoeck R. Oral treatment of oropharyngeal candidiasis with nystatin versus ketoconazole in cancer patients. Drug Invest\r\n\r\n. 1990, 2:71-5. 10.1007\/BF03258243","journal-title":"Drug Invest"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2007.00855.x","article-title":"Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial","volume":"17","author":"Corv\u00f2 R","year":"2008","unstructured":"Corv\u00f2 R, Amichetti M, Ascarelli A, et al.. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. Eur J Cancer Care (Engl). 2008, 17:270-7. 10.1111\/j.1365-2354.2007.00855.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00365855","article-title":"Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study","volume":"3","author":"Egger T","year":"1995","unstructured":"Egger T, Gratwohl A, Tichelli A, et al.. Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study. Support Care Cancer. 1995, 3:139-46. 10.1007\/BF00365855","journal-title":"Support Care Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/BF02026116","article-title":"Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients","volume":"13","author":"Ellis ME","year":"1994","unstructured":"Ellis ME, Clink H, Ernst P, et al.. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis. 1994, 13:3-11. 10.1007\/BF02026116","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll AH","year":"1997","unstructured":"Groll AH, Just-Nuebling G, Kurz M, et al.. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer. J Antimicrob Chemother. 1997, 40:855-62. 10.1093\/jac\/40.6.855","journal-title":"J Antimicrob Chemother"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study","volume":"147","author":"Hansen RM","year":"1987","unstructured":"Hansen RM, Reinerio N, Sohnle PG, Abrams RA, Ritch PS, Libnoch JA, Anderson T. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study. Arch Intern Med. 1987, 147:710-2. 10.1001\/archinte.1987.00370040092016","journal-title":"Arch Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group","volume":"13","author":"Ninane J","year":"1994","unstructured":"Ninane J. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 1994, 13:330-7. 10.1007\/BF01974614","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1984.00350140096014","article-title":"Prophylaxis of oral candidiasis with clotrimazole troches","volume":"144","author":"Owens NJ","year":"1984","unstructured":"Owens NJ, Nightingale CH, Schweizer RT, Schauer PK, Dekker PT, Quintiliani R. Prophylaxis of oral candidiasis with clotrimazole troches. Arch Intern Med. 1984, 144:290-3. 10.1001\/archinte.1984.00350140096014","journal-title":"Arch Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group","volume":"31","author":"Philpott-Howard JN","year":"1993","unstructured":"Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. J Antimicrob Chemother. 1993, 31:973-84. 10.1093\/jac\/31.6.973","journal-title":"J Antimicrob Chemother"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.supplement_3.s369","article-title":"Prophylaxis of oropharyngeal candidiasis with fluconazole","volume":"12 Suppl 3","author":"Samonis G","year":"1990","unstructured":"Samonis G, Rolston K, Karl C, Miller P, Bodey GP. Prophylaxis of oropharyngeal candidiasis with fluconazole. Rev Infect Dis. 1990, 12 Suppl 3:S369-73. 10.1093\/clinids\/12.supplement_3.s369","journal-title":"Rev Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/07357908709170099","article-title":"A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients","volume":"4","author":"Vogler WR","year":"1987","unstructured":"Vogler WR, Malcom LG, Winton EF. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients. Cancer Invest\r\n. 1987, 4:267-73. 10.1080\/07357908709170099","journal-title":"Cancer Invest"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950030309","article-title":"Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia","volume":"3","author":"Williams C","year":"1977","unstructured":"Williams C, Whitehouse JM, Lister TA, Wrigley PF. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia. Med Pediatr Oncol. 1977, 3:275-80. 10.1002\/mpo.2950030309","journal-title":"Med Pediatr Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.12.1668","article-title":"Prophylaxis of oropharyngeal candidiasis with clotrimazole","volume":"3","author":"Yeo E","year":"1985","unstructured":"Yeo E, Alvarado T, Fainstein V, Bodey GP. Prophylaxis of oropharyngeal candidiasis with clotrimazole. J Clin Oncol. 1985, 3:1668-71. 10.1200\/JCO.1985.3.12.1668","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(99)00102-1","article-title":"A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group","volume":"8","author":"Young GA","year":"1999","unstructured":"Young GA, Bolsy A, Gibbs DL, Durrant S. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group. Eur J Cancer. 1999, 8:1208-13. 10.1016\/s0959-8049(99)00102-1","journal-title":"Eur J Cancer"},{"key":"ref44","article-title":"Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg\/d and 400 mg\/d doses","volume":"67","author":"Scrimgeour E","year":"1985","unstructured":"Scrimgeour E, Anderson JD. Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg\/d and 400 mg\/d doses. S Afr Med J. 1985, 67:1044-5.","journal-title":"S Afr Med J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2219-2226.2000","article-title":"Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors","volume":"38","author":"Leung WK","year":"2000","unstructured":"Leung WK, Dassanayake RS, Yau JY, Jin LJ, Yam WC, Samaranayake LP. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol. 2000, 38:2219-26. 10.1128\/JCM.38.6.2219-2226.2000","journal-title":"J Clin Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6831-12-22","article-title":"Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols","volume":"12","author":"Panghal M","year":"2012","unstructured":"Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 2012, 12:22. 10.1186\/1472-6831-12-22","journal-title":"BMC Oral Health"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01507-8","article-title":"Oral health in patients with history of head and neck cancer: complexity and benefits of a targeted oral healthcare pathway","volume":"26","author":"Florimond M","year":"2024","unstructured":"Florimond M, Duong LT, Lours E, Brau JJ, Ferr\u00e9 FC, Fouilloux I, Boukpessi T. Oral health in patients with history of head and neck cancer: complexity and benefits of a targeted oral healthcare pathway. Curr Oncol Rep. 2024, 26:258-71. 10.1007\/s11912-024-01507-8","journal-title":"Curr Oncol Rep"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.295.3493","article-title":"Investigation of the oral infections and manifestations seen in patients with advanced cancer","volume":"29","author":"Xu L","year":"2013","unstructured":"Xu L, Zhang H, Liu J, Chen X. Investigation of the oral infections and manifestations seen in patients with advanced cancer. Pak J Med Sci. 2013, 29:1112-5. 10.12669\/pjms.295.3493","journal-title":"Pak J Med Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90199-e","article-title":"Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck","volume":"76","author":"Epstein JB","year":"1993","unstructured":"Epstein JB, Freilich MM, Le ND. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol . 1993, 76:169-74. 10.1016\/0030-4220(93)90199-e","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.11.002","article-title":"The oral microbiota and its role in carcinogenesis","volume":"86","author":"Stasiewicz M","year":"2022","unstructured":"Stasiewicz M, Karpi\u0144ski TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2022, 86:633-42. 10.1016\/j.semcancer.2021.11.002","journal-title":"Semin Cancer Biol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03144-21","article-title":"Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo","volume":"13","author":"Vadovics M","year":"2021","unstructured":"Vadovics M, Ho J, Igaz N, et al.. Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo. mBio. 2021, 13:e0314421. 10.1128\/mBio.03144-21","journal-title":"mBio"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-021-01721-x","article-title":"An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study","volume":"21","author":"Chitapanarux I","year":"2021","unstructured":"Chitapanarux I, Wongsrita S, Sripan P, Kongsupapsiri P, Phakoetsuk P, Chachvarat S, Kittidachanan K. An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study. BMC Oral Health. 2021, 21:353. 10.1186\/s12903-021-01721-x","journal-title":"BMC Oral Health"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080637","article-title":"Comparative efficacy of antifungal agents used in the treatment of oropharyngeal candidiasis among HIV-infected adults: a systematic review and network meta-analysis","volume":"7","author":"Rajadurai SG","year":"2021","unstructured":"Rajadurai SG, Maharajan MK, Veettil SK, Gopinath D. Comparative efficacy of antifungal agents used in the treatment of oropharyngeal candidiasis among HIV-infected adults: a systematic review and network meta-analysis. J Fungi (Basel). 2021, 7:10.3390\/jof7080637","journal-title":"J Fungi (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-02950-y","article-title":"Identification and susceptibility testing of oral candidiasis in advanced cancer patients","volume":"23","author":"Monsen RE","year":"2023","unstructured":"Monsen RE, Kristoffersen AK, Gay CL, et al.. Identification and susceptibility testing of oral candidiasis in advanced cancer patients. BMC Oral Health. 2023, 23:223. 10.1186\/s12903-023-02950-y","journal-title":"BMC Oral Health"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:e1-50. 10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole","volume":"46","author":"Zimmermann T","year":"1994","unstructured":"Zimmermann T, Yeates RA, Laufen H, Pfaff G, Wildfeuer A. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol. 1994, 46:147-50. 10.1007\/BF00199879","journal-title":"Eur J Clin Pharmacol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001972.pub4","article-title":"Interventions for treating oral candidiasis for patients with cancer receiving treatment","volume":"2010","author":"Worthington HV","year":"2010","unstructured":"Worthington HV, Clarkson JE, Khalid T, Meyer S, McCabe M. Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2010, 2010:CD001972. 10.1002\/14651858.CD001972.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12579","article-title":"A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients","volume":"42","author":"Leonart LP","year":"2017","unstructured":"Leonart LP, Tonin FS, Ferreira VL, Penteado ST, Wiens A, Motta FA, Pontarolo R. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients. J Clin Pharm Ther. 2017, 42:530-8. 10.1111\/jcpt.12579","journal-title":"J Clin Pharm Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Br\u00fcggemann RJ","year":"2009","unstructured":"Br\u00fcggemann RJ, Alffenaar JW, Blijlevens NM, Billaud EM, Kosterink JG, Verweij PE, Burger DM. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis. 2009, 48:1441-58. 10.1086\/598327","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/291842-the-efficacy-and-safety-of-antifungal-agents-for-managing-oral-candidiasis-in-oncologic-patients-a-systematic-review-with-network-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T14:22:14Z","timestamp":1726237334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/291842-the-efficacy-and-safety-of-antifungal-agents-for-managing-oral-candidiasis-in-oncologic-patients-a-systematic-review-with-network-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.69340","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}